Schumer, Toomey resolve COVID-19 relief sticking point, potentially setting stage for vote
The Senate appeared to reach a major breakthrough in COVID-19 relief negotiations late Saturday, and Senate Minority Leader Chuck Schumer (D-N.Y.) said he believes both the House and Senate will vote on a package Sunday so long as "nothing gets in the way."
Schumer and Sen. Pat Toomey (R-Pa.) were finishing up details of a compromise that seemingly resolves a sticking point about the Federal Reserve's ability to set up emergency lending programs without congressional approval, which Toomey wanted to restrict. Under the deal, The Wall Street Journal reports, the central bank wouldn't lose that power, but its options would be narrower — the Fed wouldn't be able to replicate programs identical to the ones it started in March unless Congress signed off.
A spokesman for Senate Majority Leader Mitch McConnell said the resolution means "we can begin closing out the rest of the package to deliver much-needed relief to families, workers, and businesses."
The Week
Escape your echo chamber. Get the facts behind the news, plus analysis from multiple perspectives.
Sign up for The Week's Free Newsletters
From our morning news briefing to a weekly Good News Newsletter, get the best of The Week delivered directly to your inbox.
From our morning news briefing to a weekly Good News Newsletter, get the best of The Week delivered directly to your inbox.
The finer details of the $900 billion proposal are still unclear, and talks could still hit a snag over certain issues, but should it go through, per CNN, the bill is expected to include $300 per week in enhanced unemployment benefits, $600 direct payments for individuals, $330 billion for small business loans, more than $80 billion for schools, and billions more for COVID-19 vaccine distribution. Read more at CNN and The Wall Street Journal.
A free daily email with the biggest news stories of the day – and the best features from TheWeek.com
Tim is a staff writer at The Week and has contributed to Bedford and Bowery and The New York Transatlantic. He is a graduate of Occidental College and NYU's journalism school. Tim enjoys writing about baseball, Europe, and extinct megafauna. He lives in New York City.
-
The Icelandic women’s strike 50 years onIn The Spotlight The nation is ‘still no paradise’ for women, say campaigners
-
Mall World: why are people dreaming about a shopping centre?Under The Radar Thousands of strangers are dreaming about the same thing and no one sure why
-
Why scientists are attempting nuclear fusionThe Explainer Harnessing the reaction that powers the stars could offer a potentially unlimited source of carbon-free energy, and the race is hotting up
-
FDA OKs generic abortion pill, riling the rightSpeed Read The drug in question is a generic version of mifepristone, used to carry out two-thirds of US abortions
-
RFK Jr. vaccine panel advises restricting MMRV shotSpeed Read The committee voted to restrict access to a childhood vaccine against chickenpox
-
Texas declares end to measles outbreakSpeed Read The vaccine-preventable disease is still spreading in neighboring states, Mexico and Canada
-
RFK Jr. shuts down mRNA vaccine funding at agencySpeed Read The decision canceled or modified 22 projects, primarily for work on vaccines and therapeutics for respiratory viruses
-
Measles cases surge to 33-year highSpeed Read The infection was declared eliminated from the US in 2000 but has seen a resurgence amid vaccine hesitancy
-
Kennedy's vaccine panel signals skepticism, changeSpeed Read RFK Jr.'s new vaccine advisory board intends to make changes to the decades-old US immunization system
-
Kennedy ousts entire CDC vaccine advisory panelspeed read Health Secretary RFK Jr. is a longtime anti-vaccine activist who has criticized the panel of experts
-
RFK Jr. scraps Covid shots for pregnant women, kidsSpeed Read The Health Secretary announced a policy change without informing CDC officials
